奖赏回路功能连接与快感缺失症状作为高炎症抑郁症治疗靶点:多巴胺激发研究证据
本研究在未用药的成年抑郁症门诊患者中,按血浆C反应蛋白(CRP)水平分层,采用双盲随机交叉设计,分别进行左旋多巴(L-DOPA;250 mg)和安慰剂急性激发,评估腹侧纹状体至腹内侧前额叶皮层奖赏回路静息态功能连接(rsFC)。结果确定CRP > 2 mg/L为患者对L-DOPA versus 安慰剂显示正向FC反应(后减前)的分界点(p < 0.01),并在全部40例有激发后rsFC数据的患者中确认CRP > 2 mg/L者L-DOPA后FC更高(B = 0.15,p = 0.006)。仅在CRP > 2 mg/L患者中,L-DOPA后快感缺失评分变化与rsFC负相关(r = -0.56,p = 0.012)。
要点
- CRP > 2 mg/L被确定为MDD患者对L-DOPA versus 安慰剂显示正向rsFC反应的分界点(p < 0.01)。
- 全部40例有激发后rsFC数据的患者中,CRP > 2 mg/L者L-DOPA后rsFC更高(B = 0.15,p = 0.006)。
- 仅在CRP > 2 mg/L患者中,L-DOPA后快感缺失评分变化与rsFC负相关(r = -0.56,p = 0.012)。
核心结论
- 奖赏回路功能连接应在更大样本中进一步验证,作为包括多巴胺能药物在内的潜在治疗在高炎症MDD患者中靶点结合的生物标志物。
研究设计与样本
- 医学稳定、未用药的成年MDD门诊患者入组时覆盖一定范围的炎症水平(以血浆CRP指数衡量),在两个访视中接受L-DOPA(250 mg)和安慰剂急性激发(双盲、随机顺序、约间隔1周)。
- 主要结局为经典腹侧纹状体至腹内侧前额叶皮层奖赏回路的静息态功能连接(rsFC),采用靶向、先验方法计算。
- 激发前后均有数据者n = 31/40,用于确立rsFC跨访视稳定性并确定CRP分界点;全部有激发后rsFC数据者n = 40用于确认分析。
主要发现
- 激发前后均有数据的患者(n = 31/40)中,rsFC跨访视稳定,并确定CRP > 2 mg/L为患者对L-DOPA versus 安慰剂显示正向FC反应(后减前)的分界点(p < 0.01)。
- 全部有激发后rsFC数据的患者(n = 40)中,CRP > 2 mg/L者L-DOPA后FC更高(B = 0.15,p = 0.006)。
- 在奖赏预期期间有任务态FC(tbFC)数据的患者中,同样确认CRP > 2 mg/L者L-DOPA后FC更高(B = 0.15,p = 0.013)。
- 扫描外努力型动机与rsFC正相关,独立于治疗或CRP。
- 仅在CRP > 2 mg/L患者中,L-DOPA后快感缺失评分变化与rsFC负相关(r = -0.56,p = 0.012)。
关键数值与推荐
- CRP > 2 mg/L作为患者对L-DOPA versus 安慰剂显示正向FC反应(后减前)的分界点(p < 0.01)。
- L-DOPA急性激发剂量为250 mg。
临床怎么用
- 原文指出奖赏回路FC应进一步在更大样本中验证,作为包括多巴胺能药物在内的潜在治疗在高炎症MDD患者中靶点结合的生物标志物。
局限性
- 原文未述局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Increased inflammation in major depressive disorder (MDD) has been associated with low functional connectivity (FC) in corticostriatal reward circuits and symptoms of anhedonia, relationships which may involve the impact of inflammation on synthesis and release of dopamine. To test this hypothesis while establishing a platform to examine target engagement of potential therapies in patients with increased inflammation, medically stable unmedicated adult MDD outpatients enrolled to have a range of inflammation (as indexed by plasma C-reactive protein [CRP] levels) were studied at two visits involving acute challenge with the dopamine precursor levodopa (L-DOPA; 250 mg) and placebo (double-blind, randomized order ~1-week apart). The primary outcome of resting-state (rs)FC in a classic ventral striatum to ventromedial prefrontal cortex reward circuit was calculated using a targeted, a priori approach. Data available both pre- and post-challenge (n = 31/40) established stability of rsFC across visits and determined CRP > 2 mg/L as a cut-point for patients exhibiting positive FC responses (post minus pre) to L-DOPA versus placebo (p < 0.01). Higher post-L-DOPA FC in patients with CRP > 2 mg/L was confirmed in all patients (n = 40) where rsFC data were available post-challenge (B = 0.15, p = 0.006), and in those with task-based (tb)FC during reward anticipation (B = 0.15, p = 0.013). While effort-based motivation outside the scanner positively correlated with rsFC independent of treatment or CRP, change in anhedonia scores negatively correlated with rsFC after L-DOPA only in patients with CRP > 2 mg/L (r = -0.56, p = 0.012). FC in reward circuitry should be further validated in larger samples as a biomarker of target engagement for potential treatments including dopaminergic agents in MDD patients with increased inflammation.
引用
- Bekhbat M, Li Z, Mehta ND, et al. Functional connectivity in reward circuitry and symptoms of anhedonia as therapeutic targets in depression with high inflammation: evidence from a dopamine challenge study. Mol Psychiatry. 2022. PMID: 35927580. doi:10.1038/s41380-022-01715-3
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。